Document:

<PAGE>

                              EMPLOYMENT AGREEMENT

     EMPLOYMENT AGREEMENT dated February 26, 2002 by and between NexMed, Inc., a
Nevada corporation (the "Company") and Dr. Y. Joseph Mo (the "Executive").

     WHEREAS, the Company desires to continue to employ Executive and to enter
into an agreement (the "Agreement") embodying the terms of such employment;

     WHEREAS, the Company considers it essential to its best interests and the
best interests of its stockholders to foster the continued employment of
Executive by the Company during the term of this Agreement; and

     WHEREAS, Executive is willing to accept and continue his employment on the
terms hereinafter set forth in this Agreement.

     NOW, THEREFORE, in consideration of the premises and mutual covenants
herein and for other good and valuable consideration, the parties agree as
follows:

     1. Term of Employment. Subject to earlier termination in accordance with
the provisions of Section 8 of this Agreement, Executive shall be employed by
the Company for a period commencing on January 1, 2002 (the "Effective Date")
and ending on December 31, 2006; provided, however, that, commencing on the day
immediately succeeding the Effective Date, and on each day thereafter, the term
of this Agreement shall be extended for one additional day so that a constant
five-year term shall be in effect (the " Employment Term").

     2. Position.

          (a) During the Employment Term, Executive shall be employed as the
     Chief Executive Officer ("CEO") and the President of the Company, and shall
     direct and manage the business, affairs, and property of the Company
     subject to the direction of the Company's Board of Directors (the "Board").
     Executive shall also serve as the CEO and President of such subsidiaries of
     the Company as the Board may in its discretion require.

          (b) During the Employment Term, Executive shall devote all of his
     business time and attention to the performance of his duties hereunder
     faithfully and to the best of his abilities and shall not undertake
     employment with, or participate in, the conduct of the business affairs of

<PAGE>

                                                                               2

     any other person, corporation, or entity; provided, that, nothing shall
     preclude Executive from (i) with the prior written approval of the Board,
     serving in due course as a director, trustee or member of a committee of
     any organization (ii) participating in the affairs of any recognized
     charitable organizations, or in any community affairs, of Executive's
     choice; and (iii) managing his personal and family affairs and investments;
     provided, that, such investments do not involve Executive's active
     participation in the affairs of the entities in which he so invests.

          (c) Executive's duties hereunder shall be performed for the Company
     worldwide, with particular emphasis in the Company's headquarters in
     Robbinsville, New Jersey.

          3. Compensation.

          (a) Base Salary. During the Employment Term, the Company shall pay
     Executive a base salary, subject to increase at the discretion of the
     Board, at the annual rate of $250,000 (the "Base Salary"), payable in
     regular installments in accordance with the Company's usual payroll dates
     practices; provided, however, that, the Base Salary shall be increased to
     an annual rate of $350,000 immediately following the completion of a period
     consisting of two consecutive of the Company's fiscal quarters during which
     the Company has achieved at least $10,000,000 in gross revenues (the
     "Salary Increase Date"). Commencing on the first anniversary of the
     Effective Date (and if the Employment Term continues on and after such
     date, on each successive anniversary of the Effective Date), Executive
     shall be entitled to an annual percentage increase (but not decrease) in
     Base Salary of no less than an amount equal to the aggregate preceding
     twelve (12) months annual percentage increase of the U.S. Department of
     Labor Consumer Price Index for All Urban Consumers (CPI-U) for the New
     York-Northern-New Jersey-Long Island, NY-NJ-CT-PA area.

          (b) Bonus. With respect to each calendar year during the Employment
     Term, Executive shall be eligible to earn an annual bonus award (the
     "Bonus"). The amount of the Bonus shall be determined by the Board, or the
     Compensation Committee of the Board (the "Compensation Committee"), in its
     sole discretion, based upon the achievement by the Company of objective
     financial targets established and determined by the Board or the
     Compensation Committee in consultation with Executive no later than the end
     of the first month of such calendar year. The Bonus in respect of each
     calendar year in the Employment Term shall be paid within ten (10) days
     following the delivery of the Company's audited financial statements for
     such year.

<PAGE>

                                                                               3

          (c) Stock Option Grant.

                    (i) Within fifteen (15) business days of the execution of
               this Agreement, the Compensation Committee shall grant to
               Executive an option to purchase 300,000 shares of the Company's
               common stock (the "Option") at the fair market value of such
               stock on the date of grant (the "Grant Date"), and with terms and
               conditions substantially identical to those contained in
               Executive's January 2000 option grant.

                    (ii) In addition, on each of the first and second
               anniversaries of the Grant Date respectively, provided that
               Executive remains employed by the Company on each such date, the
               Compensation Committee shall grant to Executive an option to
               purchase 300,000 shares of the Company's common stock (the
               "Additional Options") at the fair market value of such stock on
               the date of each such grant, and with terms and conditions
               substantially identical to those contained in Executive's January
               2000 option grant.

                    (iii) The Option and the Additional Options shall be subject
               to The NexMed, Inc. Stock Option and Long-Term Incentive
               Compensation Plan (the "Option Plan") and the applicable stock
               option agreement. The Option and the Additional Options shall to
               the greatest extent allowable be "incentive stock options" within
               the meaning of Section 422 of the Internal Revenue Code of 1986,
               as amended (the "Code").

          4. Deferred Compensation.

          (a) Executive shall be paid, commencing on the times set forth in
     Section 8 of this Agreement, deferred compensation (the "Deferred
     Compensation") at an annual rate of (X) fifty percent (50%) of his "Final
     Average Pay" (as defined below) multiplied by (Y) the "Vesting Percentage"
     (as defined below). For purposes of this Agreement, the term "Final Average
     Pay" shall mean an amount equal to (i) the total of the sum of the Base
     Salary and Bonus paid to Executive during the last thirty-six (36) calendar
     months of Executive's employment preceding the calendar month in which
     Executive becomes entitled to commence receiving the Deferred Compensation,
     divided by (ii) three (3); provided, however, that, in no event shall the
     Deferred Compensation exceed ninety percent (90%) of Executive's last rate
     of annual Base Salary preceding the time at which Executive becomes
     entitled to commence receiving the Deferred Compensation. The amount of the
     Deferred Compensation shall be restated to a monthly amount by dividing
     such amount by twelve (the "Monthly Amount") and, other than as described
     in Section 8(b)(iii) below, the Monthly Amount shall be paid monthly, to
     Executive or Executive's estate, as the case may be, beginning on the
     applicable date set forth in Section 8 of this Agreement, for a period of
     180 months.

<PAGE>

                                                                               4

     Except as otherwise provided in this Agreement, the "Vesting Percentage"
     shall be determined in accordance with the following schedule; provided,
     that, Executive remains in the employ of the Company on each vesting date:

       VESTING DATE                         VESTING PERCENTAGE
       ------------                         ------------------
     January 1, 2002                                30%
     January 1, 2003                                44%
     January 1, 2004                                58%
     January 1, 2005                                72%
     January 1, 2006                                86%
     January 1, 2007                               100%

     Notwithstanding anything to the contrary contained in this Section 4, the
     Monthly Amount payable to Executive in any calendar month shall be reduced
     to the extent of the monthly single-life annuity payable to Executive for
     such month under any qualified or nonqualified defined benefit pension plan
     of the Company (a "Pension Plan"); provided, however, that, if any benefit
     accrued by Executive under a Pension Plan prior to the payment of any
     Monthly Amount is not payable during the applicable month, or is payable in
     a form other than a single-life annuity, then such accrued benefit shall be
     converted into an equivalent value of a single-life annuity payable during
     the applicable month, and such amount used to reduce the Monthly Amount for
     such month. Any such conversion shall be performed by the Company's
     actuaries using actuarial assumptions then applicable to benefit
     determinations under the relevant Pension Plan.

          (b) Executive's rights to the Deferred Compensation shall be solely
     those of an unsecured general creditor of the Company, and nothing herein
     shall be deemed to give Executive any right to particular assets of the
     Company or to require the Company to establish a fund or trust for the
     benefit of Executive or otherwise set aside assets for his benefit;
     provided, however, that, upon the occurrence of a "Change in Control" (as
     defined in Appendix A hereto), the Company shall create and pay to a
     so-called "rabbi trust" the amounts determined by the Company's actuaries
     as necessary for the Company to completely fund the Deferred Compensation
     obligation.

          (c) The Deferred Compensation described in this Section 4 is not
     intended to constitute a "pension plan," as defined in Section 3(2) of the
     Employee Retirement Income Security Act of 1974, as amended ("ERISA"). If
     it is determined that the Deferred Compensation does

<PAGE>

                                                                               5

     constitute a pension plan under ERISA, then it shall be considered to be an
     "unfunded plan for a select group of management or highly compensated
     employees," or a so-called "top-hat plan," for purposes of ERISA. If the
     Deferred Compensation is a "top-hat plan," the claims procedure set forth
     on Appendix B hereto shall apply.

     5. Employee Benefits. During the Employment Term, Executive shall be
eligible for inclusion, to the extent permitted by law, as a full-time employee
of the Company or any of its subsidiaries, in any and all of the following
plans, programs, and policies in effect at the time: (i) pension, profit
sharing, savings, and other retirement plans and programs, (ii) life and health
(medical, dental, hospitalization, short-term and long-term disability)
insurance plans and programs, (iii) stock option and stock purchase plans and
programs, (iv) accidental death and dismemberment protection plans and programs,
(v) travel accident insurance plans and programs, (vi) vacation policy, and
(vii) other plans and programs sponsored by the Company or any subsidiary for
employees or executives generally, including any and all plans and programs that
supplement any or all of the foregoing types of plans or programs.

     In addition, during the Employment Term, the Company shall maintain, and
pay the premiums on, a contract of split-dollar life insurance on Executive's
life in the amount of $2,000,000, which contract will provide for a payment, as
a result of Executive's death, of $1,500,000 to Executive's designated
beneficiary or beneficiaries, and $500,000 to the Company. The Company shall
provide written proof of payments of such premiums to Executive within fifteen
(15) days of the due date of each premium and, if the Company fails to provide
such proof and has not paid such premium, Executive shall be entitled to pay the
unpaid premium and be reimbursed by the Company.

     6. Business Expenses and Perquisites.

          (a) The Company shall reimburse to Executive, or pay directly, all
     reasonable expenses incurred by Executive in connection with the business
     of the Company, and its subsidiaries and affiliates, including but not
     limited to business-class travel, reasonable accommodations, and
     entertainment, subject to documentation in accordance with the Company's
     policy. In this connection, if Executive determines that certain events
     will require the attendance of Executive's spouse, and Executive obtains
     advance approval from any member of the Compensation Committee, this
     Section 6(a) shall apply to expenses incurred by Executive in connection
     with his spouse's attendance at such events.

          (b) During the Employment Term, (i) the Company shall provide an
     automobile for Executive's business use, (ii) the Company shall pay the
     annual dues, but not in excess of $10,000, for Executive's membership at a
     social club of Executive's choice, and (iii) the Company shall reimburse to
     Executive, or pay directly, but not in excess of $20,000 per calendar year,
     the amounts payable by Executive to any person or

<PAGE>

                                                                               6

     persons of Executive's choice that Executive retains to advise him with
     regard to financial, investment and/or estate planning and tax matters upon
     submission by Executive to the Company of statements for services;
     provided, however, that, this Section 6(b) shall not become effective until
     the Salary Increase Date.

     7. Exercise Loan for Previously Granted Options. With respect to stock
options previously granted to Executive by the Company under the Company's
Recognition and Retention Stock Incentive Plan, and the Option Plan (the
"Previously Granted Options") pursuant to four option agreements dated December
4 and December 16, 1996, January 2, 1999, and January 18, 2000, respectively,
the Company shall loan to Executive, at such time and times that Executive
exercises the Previously Granted Options, if Executive so requests in writing,
up to an aggregate of $2,000,000 (each separate loan a "Loan"); provided,
however, that, no Loan shall be made if the aggregate of the outstanding balance
of all Loans, including the one then proposed to be made, would exceed ten
percent (10%) of the aggregate of the Company's cash and cash equivalents as of
the last day of the month immediately preceding the month in which such Loan is
requested to be made; and provided, further, that, a Loan shall not be made if
(i) the Company's independent accounting firm determines that the making of such
Loan will cause the Company to incur an accounting charge to earnings for
compensation or (ii) it would cause a default, or an event of default, under any
of the credit agreements, notes, security agreements, or other debt or equity
financing documents to which the Company is subject. Each Loan (w) shall have,
except as otherwise stated in this Agreement, a principal and accrued interest
due date of three months from the date that the Loan is made to Executive or, if
Executive dies prior to the due date of such Loan, seven months from the date
the Loan is made to Executive, (x) shall bear interest, payable monthly, at a
rate equal to the applicable Federal rate (short-term), as determined in
accordance with Section 1274(d) of the Code, (y) shall be secured by the shares
issued to Executive upon the exercise of the Previously Granted Options to which
such Loan relates, provided that such shares may be sold by Executive subject to
the last sentence of this Section 7, and (z) shall be subject to such standard
terms and conditions, and the execution of such documentation consistent with
this Section 7, as the Company shall reasonably determine. Notwithstanding the
foregoing, at any time that Executive sells any of the shares issued to
Executive upon the exercise of any of the Previously Granted Options while the
amount of any Loan remains unpaid, Executive shall, within five days of receipt
of the funds from such sale, pay to the Company, the after-tax proceeds of such
sale, as a prepayment of such Loan or Loans, up to the unpaid balance of each
Loan (including accrued interest).

     8. Termination.

          (a) By the Company for Cause. The Company may, for Cause, terminate
     Executive's employment hereunder at any time by written notice to
     Executive. For purposes of this Agreement, the term "Cause" shall mean
     Executive's (i) engaging in fraud against the Company or misappropriation
     of funds of the Company, (ii) disregard or willful failure to follow
     specific and reasonable directives of the Board, (iii) willful

<PAGE>

                                                                               7

     failure to perform his duties as CEO and President of the Company and/or
     one of its subsidiaries, (iv) willful misconduct resulting in material
     injury to the Company, (v) willful violation of the terms of the
     Confidential Information and Intellectual Property Agreement between
     Executive and NexMed (U.S.A.), Inc., a wholly-owned subsidiary of the
     Company, dated October 4, 2000 (the "Intellectual Property Agreement")
     attached hereto as Exhibit "A", (vi) conviction of, or Executive's plea of
     guilty or no contest to, a felony or any crime involving as a material
     element fraud or dishonesty, or (vii) material breach (not covered by
     clauses (i) through (vi)) of any of the other provisions of this Agreement;
     provided, that, in the case of subclauses (ii), (iii) or (vii), Cause shall
     not exist if the act or omission deemed to constitute Cause is cured (if
     curable) by Executive within thirty (30) days after written notice thereof
     to Executive by the Company. For purposes of the foregoing, no act, or
     failure to act, on Executive's part shall be considered "willful" unless
     done, or omitted to be done, by Executive other than in good faith, and
     without reasonable belief that his action or omission was in furtherance of
     the interests of the Company.

          In the event of the termination of Executive's employment under this
     Section 8(a) for Cause, the Employment Term shall end on the day of such
     termination and the Company shall pay to Executive, no later than ten (10)
     days after the last day of Executive's employment, in one lump sum, the sum
     of (i) any accrued but unpaid Base Salary, including salary in respect of
     any accrued and accumulated vacation, due to Executive at the date of such
     termination, (ii) any earned and unpaid Bonus due to Executive at the date
     of such termination for the calendar year ending immediately prior to the
     date of such termination, and (iii) any amounts owing, but not yet paid,
     pursuant to Section 6(a) hereof. In addition, in the event of the
     termination of Executive's employment under this Section 8(a) for Cause,
     (A) the Vesting Percentage in respect of the Deferred Compensation shall be
     zero, with the result that the Deferred Compensation shall be forfeited,
     and (B) the principal and accrued interest on each Loan shall become
     immediately due and payable.

     Except as specifically set forth in Section 12 hereof, the Company shall
     have no further obligations to Executive under this Agreement.

          (b) Disability or Death. If Executive should suffer a Permanent
     Disability, the Company may terminate Executive's employment hereunder upon
     ten (10) or more days' prior written notice to Executive. For purposes of
     this Agreement, a "Permanent Disability" shall be deemed to have occurred
     only when Executive has qualified for benefits (including satisfaction of
     any applicable waiting period) under the Company's or a subsidiary's
     long-term disability insurance arrangement (the "LTD Policy"). In the event
     of the termination of Executive's employment hereunder by reason of
     Permanent Disability or death, the

<PAGE>

                                                                               8

     Employment Term shall end on the day of such termination and the Company
     shall pay:

               (i) No later than ten days after the last day of Executive's
          employment, to Executive or Executive's legal representative (in the
          event of Permanent Disability), or any beneficiary or beneficiaries
          designated by Executive to the Company in writing, or to Executive's
          estate if no such beneficiary has been so designated (in the event of
          Executive's death), a single lump sum payment of (x) any accrued but
          unpaid Base Salary, including salary in respect of any accrued and
          accumulated vacation, due to Executive at the date of such
          termination, (y) any earned but unpaid Bonus due to Executive at the
          date of such termination for the calendar year ending immediately
          prior to the date of each termination, and (z) any amounts owing, but
          not yet paid, pursuant to Section 6(a) hereof;

               (ii) In the case of a termination of employment due to Permanent
          Disability only, to Executive, in conformity with regular payroll
          dates for salaried personnel of the Company, an amount equal to fifty
          percent (50%) of the Base Salary Executive was receiving at the date
          of such termination (the "Disability Payment"), payable through the
          earlier of (i) the fifth anniversary of the date of such termination
          and (ii) January 1, 2014, in either case, at which time the Monthly
          Payments of the Deferred Compensation shall begin; provided, that, the
          Disability Payment shall be reduced for the period during which
          Executive is in receipt of benefits under the LTD Policy by the amount
          necessary to ensure that the sum of (x) Executive's monthly Disability
          Payment and (y) the "Gross Monthly Benefit" under the LTD Policy does
          not exceed 100% of his "Basic Monthly Earnings" (as defined in the LTD
          Policy); and

               (iii) In the case of a termination of employment due to death
          only, to any beneficiary or beneficiaries designated by Executive to
          the Company in writing, or to Executive's estate if no such
          beneficiary has been so designated, the Deferred Compensation, with
          payment of the present value of the entire amount of Deferred
          Compensation payable over the 180-month payment period (discounted by
          the Company's weighted average borrowing rate at the time of payment)
          being paid in one lump sum on the first day of the month immediately
          succeeding the last day of Executive's employment.

          Except as specifically set forth in Section 12 hereof, the Company
          shall have no further obligations to Executive under this Agreement.

          (c) By the Company without Cause. The Company may, without Cause,
     terminate Executive's employment hereunder at any time upon ten (10) or
     more days' written notice to Executive. In the event Executive's employment
     is terminated pursuant to this Section 8(c), the

<PAGE>

                                                                               9

     Employment Term shall end on the day of such termination and the Company
     shall pay to Executive, on the last day of Executive's employment, in one
     lump sum, the sum of (i) any accrued but unpaid Base Salary, including
     salary in respect of any accrued and accumulated vacation, due to Executive
     at the date of such termination, (ii) any earned but unpaid Bonus due to
     Executive at the date of such termination for the calendar year ending
     immediately prior to the date of such termination, (iii) any amounts owing,
     but not yet paid, pursuant to Section 6(a) hereof, and (iv) an amount equal
     to the product of 2.9 times Executive's annual Base Salary at the time of
     such termination. Executive shall also be eligible to receive a pro rata
     Bonus in respect of the calendar year in which such termination occurs,
     equal to the Bonus in respect of such calendar year multiplied by a
     fraction, the numerator of which is the number of days in such year
     preceding and including the date of termination, and the denominator of
     which is 365. Such pro-rata Bonus shall be paid at the same time as the
     Bonus would have been paid had Executive continued being employed by the
     Company through the date of payment.

          In addition, upon termination of Executive's employment in accordance
     with this Section 8(c), the Company shall (i) reimburse Executive for
     reasonable expenses, not to exceed $10,000, incurred by Executive in
     connection with job search services, and (ii) provide medical and dental
     benefits to Executive and his family for a period of two (2) years from the
     date of termination, as are provided from time to time to actively employed
     senior executives of the Company during such period; provided, that, the
     Company's obligation in this regard shall cease at the time Executive
     becomes eligible for medical or dental benefits, respectively, from another
     employer. To the extent that the medical and dental benefits provided for
     in this paragraph are not permissible after termination of employment under
     the terms of the benefit plans of the Company then in effect (and cannot be
     provided by the Company paying the applicable premium under COBRA), the
     Company shall pay to Executive such amount as is necessary to provide
     Executive, after tax, with an amount equal to the cost of acquiring, for
     Executive and his family on a non-group basis, for the required period,
     those medical and dental benefits that would otherwise be lost to Executive
     and his family as a result of Executive's termination.

     In the event Executive's employment is terminated pursuant to this Section
     8(c), payment of the Monthly Amount shall begin on the first day of the
     month immediately succeeding the last day of Executive's employment.

     Except as specifically set forth in Section 12 hereof, the Company shall
     have no further obligations to Executive under this Agreement.

<PAGE>

                                                                              10

          (d) By Executive for Good Reason. If any of the events described below
     occurs during the Employment Term, Executive may terminate Executive's
     employment hereunder for Good Reason by written notice to the Company
     identifying the event or omission constituting Good Reason not more than
     six (6) months following the occurrence of such event and, in the case of
     subclauses (iv), (v), (vi), (vii) and (viii) below, a failure by the
     Company to cure such act or omission within thirty (30) days after receipt
     of such written notice. In such event, the Employment Term and Executive's
     employment hereunder will be terminated effective as of the later of
     thirty-one (31) days after the Company's receipt of Executive's notice of
     termination or thirty-one (31) days after the event, and Executive's
     termination for Good Reason pursuant to this Section 8(d) shall be treated
     for all purposes as a termination without Cause pursuant to Section 8(c)
     and the provisions of Section 8(c) shall apply to such termination. The
     occurrence of any of the following events without Executive's consent shall
     permit Executive to terminate Executive's employment for "Good Reason"
     pursuant to this Section 8(d):

               (i) The removal of Executive or the election of any other person
          as the Chief Executive Officer or the President of the Company;
          provided, however, that, Executive shall not have approved such
          removal or such election, in Executive's capacity as a director, by
          voting for such removal or such election;

               (ii) The removal of Executive or the election of any other person
          as the Chairman of the Board; provided, however, that, Executive shall
          not have approved such removal or such election, in Executive's
          capacity as a director, by voting for such removal or such election;

               (iii) A "Change in Control" (as defined in Appendix A hereto)
          occurs;

               (iv) The failure by the Company to observe or comply in any
          material respect with any of the material provisions of this
          Agreement;

               (v) The failure by the Compensation Committee to grant the Option
          and Additional Options as provided in Section 3(c) hereof;

               (vi) A material diminution in Executive's duties;

               (vii) The assignment to Executive of duties that are materially
          inconsistent with Executive's duties or that materially impair
          Executive's ability to function as the CEO or the President of the
          Company; and

<PAGE>

                                                                              11

               (viii) The relocation of Executive's primary office from a
          location that is more than fifty (50) miles from both of (x) the
          Company's executive offices at the time of such relocation and (y)
          Executive's primary residence at the time of such relocation.

     Except as specifically set forth in Section 12 hereof, the Company shall
have no further obligations to Executive under this Agreement.

          (e) By Executive without Good Reason. Executive may terminate the
     Employment Term and Executive's employment hereunder at any time without
     Good Reason upon thirty (30) days advance written notice to the Company. In
     the event Executive's employment is terminated pursuant to this Section
     8(e), the Company shall pay to Executive, no later than ten (10) days after
     the last day of Executive's employment, in one lump sum, the sum of (i) any
     accrued but unpaid Base Salary, including salary in respect of any accrued
     and accumulated vacation, due to Executive at the date of such termination,
     (ii) any earned and unpaid Bonus due to Executive at the date of such
     termination for the calendar year ending immediately prior to the date of
     such termination, and (iii) any amounts owing, but not yet paid, pursuant
     to Section 6(a) hereof. In addition, the monthly payments of Deferred
     Compensation shall commence on January 1, 2014.

     Except as specifically set forth in Section 12 hereof, the Company shall
have no further obligations to Executive under this Agreement.

          (f) Release. Notwithstanding any other provision of this Agreement to
     the contrary, Executive acknowledges and agrees that any and all payments
     and benefits to which Executive is entitled under this Section 8 are
     conditioned upon and subject to Executive's execution of a general waiver
     and release, in such reasonable and customary form as shall be prepared by
     the Company, of all claims Executive may have against the Company, except
     as to matters covered by provisions of this Agreement which specifically
     survive the termination of this Agreement.

     9. Certain Additional Payments by the Company.

          (a) If it is determined (as hereafter provided) that any payment or
     distribution by the Company to or for the benefit of Executive, whether
     paid or payable or distributed or distributable pursuant to the terms of
     this Agreement or otherwise pursuant to or by reason of any other
     agreement, policy, plan, program or arrangement, including without
     limitation any stock option, stock appreciation right or similar right, or
     the lapse or termination of any restriction on or the vesting or
     exercisability of any of the foregoing (a "Payment"), would be subject to
     the excise tax imposed by Section 4999 of the Code (or any successor
     provision thereto) or to any

<PAGE>

                                                                              12

     similar tax imposed by state or local law, or any interest or penalties
     with respect to such excise tax (such tax or taxes, together with any such
     interest and penalties, are hereafter collectively referred to as the
     "Excise Tax"), then Executive will be entitled to receive an additional
     payment or payments (a "Gross-Up Payment") in an amount such that, after
     payment by Executive of all taxes (including any interest or penalties
     imposed with respect to such taxes), including any Excise Tax, imposed upon
     the Gross-Up Payment, Executive retains an amount of the Gross-Up Payment
     equal to the Excise Tax imposed upon the Payments.

          (b) Subject to the provisions of Section 9(f) hereof, all
     determinations required to be made under this Section 9, including whether
     an Excise Tax is payable by Executive and the amount of such Excise Tax and
     whether a Gross-Up Payment is required and the amount of such Gross-Up
     Payment, will be made by a nationally recognized firm of certified public
     accountants (the "Accounting Firm") selected by the Company, which may be
     the Company's regular outside auditors. The Company will direct the
     Accounting Firm to submit its determination and detailed supporting
     calculations to both the Company and Executive within thirty (30) calendar
     days after the date of the Change in Control or the date of Executive's
     termination of employment, if applicable, and any other such time or times
     as may be requested by the Company or Executive. If the Accounting Firm
     determines that any Excise Tax is payable by Executive, the Company will
     pay the required Gross-Up Payment to Executive no later than five (5)
     calendar days prior to the due date for Executive's income tax return on
     which the Excise Tax is included. If the Accounting Firm determines that no
     Excise Tax is payable by Executive, it will, at the same time as it makes
     such determination, furnish Executive with an opinion that he has
     substantial authority not to report any Excise Tax on his federal, state,
     local income or other tax return. Any determination by the Accounting Firm
     as to the amount of the Gross-Up Payment will be binding upon the Company
     and Executive. As a result of the uncertainty in the application of Section
     4999 of the Code (or any successor provision thereto) and the possibility
     of similar uncertainty regarding applicable state or local tax law at the
     time of any determination by the Accounting Firm hereunder, it is possible
     that Gross-Up Payments which will not have been made by the Company should
     have been made (an "Underpayment"), consistent with the calculations
     required to be made hereunder. In the event that the Company exhausts or
     fails to pursue its remedies pursuant to Section 9(f) hereof and Executive
     thereafter is required to make a payment of any Excise Tax, Executive shall
     so notify the Company, which will direct the Accounting Firm to determine
     the amount of the Underpayment that has occurred and to submit its
     determination and detailed supporting calculations to both the Company and
     Executive as promptly as possible. Any such Underpayment will be promptly
     paid by the Company to, or for

<PAGE>

                                                                              13

     the benefit of, Executive within five business days after receipt of such
     determination and calculations.

          (c) The Company and Executive will each provide the Accounting Firm
     access to and copies of any books, records and documents in the possession
     of the Company or Executive, as the case may be, reasonably requested by
     the Accounting Firm, and otherwise cooperate with the Accounting Firm in
     connection with the preparation and issuance of the determination
     contemplated by Section 9(b) hereof.

          (d) The federal, state and local income or other tax returns filed by
     Executive will be prepared and filed on a consistent basis with the
     determination of the Accounting Firm with respect to the Excise Tax payable
     by Executive. Executive will make proper payment of the amount of any
     Excise Tax, and at the request of the Company, provide to the Company true
     and correct copies (with any amendments) of his federal income tax return
     as filed with the Internal Revenue Service and corresponding state and
     local tax returns, if relevant, as filed with the applicable taxing
     authority, and such other documents reasonably requested by the Company,
     evidencing such payment. If prior to the filing of Executive's federal
     income tax return, or corresponding state or local tax return, if relevant,
     the Accounting Firm determines that the amount of the Gross-Up Payment
     should be reduced, Executive will within five (5) business days pay to the
     Company the amount of such reduction.

          (e) The fees and expenses of the Accounting Firm for its services in
     connection with the determinations and calculations contemplated by
     Sections 9(b) and (d) hereof will be borne by the Company. If such fees and
     expenses are initially advanced by Executive, the Company will reimburse
     Executive the full amount of such fees and expenses within five business
     days after receipt from Executive of a statement therefor and reasonable
     evidence of his payment thereof.

          (f) Executive will notify the Company in writing of any claim by the
     Internal Revenue Service that, if successful, would require the payment by
     the Company of a Gross-Up Payment. Such notification will be given as
     promptly as practicable but no later than five (5) business days after
     Executive actually receives notice of such claim and Executive will further
     apprise the Company of the nature of such claim and the date on which such
     claim is requested to be paid (in each case, to the extent known by
     Executive). Executive will not pay such claim prior to the earlier of (i)
     the expiration of the 30-calendar-day period following the date on which he
     gives such notice to the Company and (ii) the date that any payment of
     amount with respect to such claim is due. If the Company notifies Executive
     in writing prior to the expiration of such period that it desires to
     contest such claim, Executive will:

<PAGE>

                                                                              14

               (i) provide the Company with any written records or documents in
          his possession relating to such claim reasonably requested by the
          Company;

               (ii) take such action in connection with contesting such claim as
          the Company will reasonably request in writing from time to time,
          including without limitation accepting legal representation with
          respect to such claim by an attorney competent in respect of the
          subject matter and reasonably selected by the Company;

               (iii) cooperate with the Company in good faith in order
          effectively to contest such claim; and

               (iv) permit the Company to participate in any proceedings
          relating to such claim;

provided, however, that, the Company will bear and pay directly all costs and
expenses (including interest and penalties) incurred in connection with such
contest and will indemnify and hold harmless Executive, on an after-tax basis,
for and against any Excise Tax or income tax, including interest and penalties
with respect thereto, imposed as a result of such representation and payment of
costs and expenses. Without limiting the foregoing provisions of this Section
9(f), the Company will control all proceedings taken in connection with the
contest of any claim contemplated by this Section 9(f) and, at its sole option,
may pursue or forego any and all administrative appeals, proceedings, hearings
and conferences with the taxing authority in respect of such claim (provided
that Executive may participate therein at his own cost and expense) and may, at
its option, either direct Executive to pay the tax claimed and sue for a refund
or contest the claim in any permissible manner, and Executive agrees to
prosecute such contest to a determination before any administrative tribunal, in
a court of initial jurisdiction and in one or more appellate courts, as the
Company will determine; provided, however, that, if the Company directs
Executive to pay the tax claimed and sue for a refund, the Company will advance
the amount of such payment to Executive on an interest-free basis and will
indemnify and hold Executive harmless, on an after-tax basis, from any Excise
Tax or income tax, including interest or penalties with respect thereto, imposed
with respect to such advance; and provided further, however, that, any extension
of the statute of limitations relating to payment of taxes for the taxable year
of Executive with respect to which the contested amount is claimed to be due is
limited solely to such contested amount. Furthermore, the Company's control of
any such contested claim will be limited to issues with respect to which a
Gross-Up Payment would be payable hereunder and Executive will be entitled to
settle or contest, as the case may be, any other issue raised by the Internal
Revenue Service or any other taxing authority.

          (g) If, after the receipt by Executive of an amount advanced by the
     Company pursuant to Section 9(f) hereof, Executive receives any refund with
     respect to such claim, Executive will (subject to the Company's complying
     with the requirements of Section 9(f) hereof) promptly pay to the Company
     the amount of such refund (together with

<PAGE>

                                                                              15

     any interest paid or credited thereon after any taxes applicable thereto).
     If, after the receipt by Executive of an amount advanced by the Company
     pursuant to Section 9(f) hereof, a determination is made that Executive
     will not be entitled to any refund with respect to such claim and the
     Company does not notify Executive in writing of its intent to contest such
     denial or refund prior to the expiration of thirty (30) calendar days after
     such determination, then such advance will be forgiven and will not be
     required to be repaid and the amount of such advance will offset, to the
     extent thereof, the amount of Gross-Up Payment required to be paid pursuant
     to this Section 9. If, after the receipt by Executive of a Gross-Up Payment
     but before the payment by Executive of the Excise Tax, it is determined by
     the Accounting Firm that the Excise Tax payable by Executive is less than
     the amount originally computed by the Accounting Firm and consequently that
     the amount of the Gross-Up Payment is larger than that required by this
     Section 9, Executive shall promptly refund to the Company the amount by
     which the Gross-Up Payment initially made to Executive exceeds the Gross-Up
     Payment required under this Section 9.

     10. Legal Fees. The Company shall reimburse to Executive, or pay directly,
upon submission to the Company of a statement for services, the amount payable
by Executive to an attorney of Executive's choice that Executive has retained to
advise Executive with regard to the negotiation and execution of this Agreement;
provided, however, that (i) the fees charged by such attorney are computed at
such attorney's standard hourly rates, and (ii) such reimbursement or payment
shall not exceed $25,000.

     11. No Mitigation; Employee Benefit Plans. Executive shall not be required
to mitigate amounts payable to him under this Agreement by seeking other
employment or otherwise, and there shall be no offset against amounts payable to
Executive under this Agreement on account of Executive's subsequent employment.
Except for amounts, if any, payable by Executive pursuant to any Loan, amounts
payable to Executive under this Agreement shall not be offset by any claims that
the Company may have against Executive, and such amounts payable to Executive
under this Agreement shall not be affected by any other circumstances,
including, without limitation, any counterclaim, recoupment, defense, or other
right that the Company may have against Executive or others. Except as otherwise
provided in this Agreement, the termination of Executive's employment hereunder
shall have no effect on the rights and obligations of the Company and Executive
under the Company's benefit plans; provided, however, that, payments made to
Executive as a result of the termination of Executive's employment hereunder
shall not be considered as includible compensation with respect to any employee
benefit plans maintained by the Company, except to the extent otherwise required
by law.

     12. Indemnification. In the event that Executive is made a party or
threatened to be made a party to any action, suit, or proceeding, whether civil,
criminal, administrative, or investigative (a "Proceeding"), by reason of
Executive's employment with, or serving as an officer of, the Company, the
Company shall indemnify and hold

<PAGE>

                                                                              16

Executive harmless, and defend Executive to the fullest extent authorized by the
laws of the state in which the Company is incorporated, as the same exist and
may hereafter be amended, against any and all claims, demands, suits, judgments,
assessments, and settlements (collectively the "Claims"), including all expenses
incurred or suffered by Executive in connection therewith (excluding, however,
any legal fees incurred by Executive for Executive's own counsel, except as
otherwise provided in this Section 12, and such indemnification shall continue
as to Executive even after Executive is no longer employed by the Company
hereunder, and shall inure to the benefit of Executive's heirs, executors, and
administrators; provided, however, that, Executive promptly gives written notice
to the Company of any such Claims (although Executive's failure to promptly give
notice shall not affect the Company's obligations under this Section 12 except
to the extent that such failure prejudices the Company or its ability to defend
such Claims). The Company shall have the right to undertake, with counsel or
other representatives of its own choosing, the defense or settlement of any
Claims. In the event that the Company shall fail to notify Executive, within ten
days of its receipt of Executive's written notice, that the Company has elected
to undertake such defense or settlement, or if at any time the Company shall
otherwise fail to diligently defend or pursue settlement of such Claims, then
Executive shall have the right to undertake the defense, compromise, or
settlement of such Claims, in which event the Company shall hold Executive
harmless from any legal fees incurred by Executive for Executive's counsel.
Neither Executive nor the Company shall settle any Claims without the prior
written consent of the other, which consent shall not be unreasonably withheld
or delayed. In the event that the Company submits to Executive a bona fide
settlement offer from the claimant of Claims (which settlement offer shall
include as an unconditional term thereof the giving by the claimant or the
plaintiff to Executive a release from all liability in respect of such Claims),
and Executive refuses to consent to such settlement, then thereafter the
Company's liability to Executive for indemnification hereunder with respect to
such Claims shall not exceed the settlement amount included in such bona fide
settlement offer, and Executive shall either assume the defense of such Claims
or pay the Company's attorneys' fees and other out-of-pocket costs incurred
thereafter in continuing the defense of such Claims. Regardless of which party
is conducting the defense of any such Claims, the other party, with counsel or
other representatives of its own choosing and at its sole cost and expense,
shall have the right to consult with the party conducting the defense of such
Claims and its counsel or other representatives concerning such Claims and
Executive and the respective counsel or other representatives shall cooperate
with respect to such Claims. The party conducting the defense of any such Claims
and its counsel shall in any case keep the other party and its counsel (if any)
fully informed as to the status of such Claims and any matters relating thereto.
Executive and the Company shall provide to the other such records, books,
documents, and other materials as shall reasonably be necessary for each to
conduct or evaluate the defense of any Claims, and will generally cooperate with
respect to any matters relating thereto. This Section 12 shall remain in effect
after this Agreement is terminated, regardless of the reasons for such
termination. The indemnification provided to Executive pursuant to this Section
12 shall not supersede or reduce any indemnification provided to Executive under
any separate agreement, or the By-Laws of the Company; in this regard, it is
intended that this Agreement shall expand and extend Executive's rights to
receive indemnification.

<PAGE>

                                                                              17

     13. Withholding. The Company shall have the right to deduct and withhold
from all payments to Executive hereunder all payroll taxes, income tax
withholding and other federal, state and local taxes and charges which currently
are or which hereafter may be required by law to be so deducted and withheld.

     14. Non-assignability. Executive's rights and benefits hereunder are
personal to Executive, and shall not be alienated, voluntarily or involuntarily
assigned, or transferred.

     15. Binding Effect. This Agreement shall be binding upon the parties
hereto, and their respective assigns, successors, executors, administrators, and
heirs. In the event the Company becomes a party to any merger, consolidation, or
reorganization, this Agreement shall remain in full force and effect as an
obligation of the Company or its successor(s) in interest. Other than in respect
of the Loans, none of the payments provided for by this Agreement shall be
subject to seizure for payment of any debts or judgments against Executive or
Executive's beneficiary or beneficiaries, nor shall Executive or any such
beneficiary or beneficiaries have any right to transfer or encumber any right or
benefit hereunder.

     16. Entire Agreement; Modification. This Agreement and the Intellectual
Property Agreement contain the entire agreement relating to Executive's
employment by the Company. These Agreements may not be changed orally, and may
be changed only by an agreement in writing signed by the parties hereto.

     17. Notices. All notices and communications hereunder shall be in writing,
sent by certified or registered mail, return receipt requested, postage prepaid;
by facsimile transmission, with proof of the time and date of receipt retained
by the transmitter; or by hand-delivery properly receipted. The actual date of
receipt as shown by the return receipt therefore, the facsimile transmission
sheet, or the hand-delivery receipt, as the case may be, shall determine the
date on which (and, in the case of a facsimile, the time at which) notice was
given. All payments required hereunder by the Company to Executive shall be sent
postage prepaid, or, at Executive's election, shall be transferred to Executive
electronically to such bank account as Executive may designate in writing to the
Company, including designation of the applicable electronic address. The
foregoing items (other than any electronic transfer to Executive) shall be
addressed as follows (or to such other address as the Company and Executive may
designate in writing from time to time):

                  To the Company:

                  NexMed, Inc.
                  350 Corporate Boulevard
                  Robbinsville, NJ 08691
                  Fax: 609-208-1868
                  Attention: Vice President, Corporate Affairs

<PAGE>

                                                                              18

                  To Executive:

                  Dr. Y. Joseph Mo, Ph.D.
                  One Belleview Terrace
                  Princeton, NJ 08540
                  Fax: 609-683-0928

     18. Governing Law; Jurisdiction. This Agreement shall be governed by, and
construed and enforced according to, the domestic laws of the State of New
Jersey without giving effect to the principles of conflict of laws thereof, or
such principles of any other jurisdiction which could cause the application of
the substantive law of any jurisdiction other than the State of New Jersey. The
Company and Executive agree that the Superior Court of the State of New Jersey,
Mercer County, shall have exclusive jurisdiction to hear and determine any
dispute which may arise under this Agreement. Service of process by the Company
may be effected by service upon Executive's designated agent: _______________,
the address of which is ________________.

     19. Severability The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement, and each other provision of the Agreement shall be
severable and enforceable to the extent permitted by law.

     20. Headings. The headings of the Sections hereof are provided for
convenience only and are not to serve as a basis for interpretation or
construction, and shall not constitute a part, of this Agreement.

     21. Signature in Counterparts. This Agreement may be signed in
counterparts, each of which shall be an original, with the same effect as if the
signatures thereto and hereto were upon the same instrument.

                  IN WITNESS WHEREOF, Executive has hereunto set his hand and
the Company has caused this Agreement to be executed in its name on its behalf,
all as of the day and year first above written.

                                               /s/ Y. Joseph Mo
                                               -----------------------------
                                               Dr. Y. Joseph Mo

                                               NEXMED, INC.

                                               By: /s/ Robert W. Gracy
                                                   --------------------------
                                               Title: Director

<PAGE>

                                                                              19

                                   APPENDIX A
                                CHANGE OF CONTROL

For the purpose of this Agreement, a "Change in Control" shall be deemed to have
taken place if:

    A.    Individuals who, on the date hereof, constitute the Board (the
          "Incumbent Directors") cease for any reason to constitute at least a
          majority of the Board, provided that any person becoming a director
          subsequent to the date hereof, whose election or nomination for
          election was approved by a vote of at least two-thirds of the
          Incumbent Directors then on the Board (either by a specific vote or by
          approval of the proxy statement of the Company in which such person is
          named as a nominee for director, without written objection to such
          nomination) shall be an Incumbent Director; provided, however, that,
          no individual initially elected or nominated as a director of the
          Company as a result of an actual or threatened election contest with
          respect to directors or as a result of any other actual or threatened
          solicitation of proxies or consents by or on behalf of any person
          other than the Board shall be deemed to be an Incumbent Director;

    B.    Any "Person" (as such term is defined in Section 3(a)(9) of the
          Securities Exchange Act of 1934 (the "Exchange Act") and as used in
          Sections 13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes a
          "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act),
          directly or indirectly, of securities of the Company representing 25%
          or more of the combined voting power of the Company's then outstanding
          securities eligible to vote for the election of the Board (the "Voting
          Securities"); provided, however, that, the event described in this
          paragraph B shall not be deemed to be a Change in Control by virtue of
          any of the following acquisitions: (i) by the Company or any
          subsidiary of the Company in which the Company owns more than 25% of
          the combined voting power of such entity (a "Subsidiary"), (ii) by any
          employee benefit plan (or related trust) sponsored or maintained by
          the Company or any Subsidiary, (iii) by any underwriter temporarily
          holding the Company's Voting Securities pursuant to a public offering
          of such Voting Securities, (iv) pursuant to a Non-Qualifying
          Transaction (as defined in paragraph C immediately below), (v)
          pursuant to any acquisition by Executive or by any Person which is an
          "affiliate" (within the meaning of 17 C.F.R.ss. 230.405) of Executive
          (an "Excluded Person");

    C.    The consummation of a merger, consolidation, statutory share exchange
          or similar form of corporate transaction involving the Company or any
          of its Subsidiaries that requires the approval of

<PAGE>

                                                                              20

          the Company's stockholders, whether for such transaction or the
          issuance of securities in the transaction (a "Business Combination"),
          unless immediately following such Business Combination: (i) more than
          25% of the total voting power of (A) the corporation resulting from
          such Business Combination (the "Surviving Corporation"), or (B) if
          applicable, the ultimate parent corporation that directly or
          indirectly has beneficial ownership of 100% of the voting securities
          eligible to elect directors of the Surviving Company (the "Parent
          Corporation"), is represented by the Company's Voting Securities that
          were outstanding immediately prior to such Business Combination (or,
          if applicable, is represented by shares into which the Company's
          Voting Securities were converted pursuant to such Business
          Combination), and such voting power among the holders thereof is in
          substantially the same proportion as the voting power of the Company's
          Voting Securities among the holders thereof immediately prior to the
          Business Combination, (ii) no Person (other than (A) any employee
          benefit plan (or related trust) sponsored or maintained by the
          Surviving Corporation or the Parent Corporation or (B) an Excluded
          Person is or becomes the beneficial owner, directly or indirectly, of
          25% or more of the total voting power of the outstanding voting
          securities eligible to elect directors of the Parent Corporation (or,
          if there is no Parent Corporation, the Surviving Corporation) and
          (iii) at least a majority of the members of the board of directors of
          the Parent Corporation (or, if there is no Parent Corporation, the
          Surviving Corporation) following the consummation of the Business
          Combination were Incumbent Directors at the time of the Board's
          approval of the execution of the initial agreement providing for such
          Business Combination (any Business Combination which satisfies all of
          the criteria specified in (i), (ii) and (iii) above shall be deemed to
          be a "Non-Qualifying Transaction");

    D.    A sale of all or substantially all of the Company's assets, other than
          to an Excluded Person;

    E.    The stockholders of the Company approve a plan of complete liquidation
          or dissolution of the Company; or

    F.    Such other events as the Board may designate.

    Notwithstanding the foregoing, a Change in Control of the Company shall not
be deemed to occur solely because any person acquires beneficial ownership of
more than 25% of the Company's Voting Securities as a result of the acquisition
of the Company's Voting Securities by the Company which reduces the number of
the Company's Voting Securities outstanding; provided, that, if after such
acquisition by the Company such person becomes the beneficial owner of
additional Company Voting

<PAGE>

                                                                              21

Securities that increases the percentage of outstanding Company Voting
Securities beneficially owned by such person, a Change in Control of the Company
shall then occur.

<PAGE>

                                                                              22

                                   APPENDIX B
                                CLAIMS PROCEDURE

     (a) All claims for payments of the Deferred Compensation shall be made in
writing and shall be signed by Executive. Claims shall be submitted to the
Company. If Executive does not furnish sufficient information with the claim for
the Company to determine the validity of the claim, the Company shall indicate
to Executive any additional information which is necessary for the Company to
determine the validity of the claim. Each claim hereunder shall be acted on and
approved or disapproved by the Company within ninety (90) days following the
receipt by the Company of the information necessary to process the claim.

In the event the Company denies a claim for payment in whole or in part, the
Company shall notify Executive in writing of the denial of the claim and notify
Executive of his right to a review of the Company's decision. Such notice by the
Company shall also set forth, in a manner calculated to be understood by
Executive, the specific reason for such denial, the specific provisions of this
Agreement (or other document) on which the denial is based, a description of any
additional material or information necessary to perfect the claim and an
explanation of the appeals procedure as set forth in this Appendix B. If no
action is taken by the Company on Executive's claim within ninety (90) days
after receipt by the Company, such claim shall be deemed to be denied for
purposes of the following appeals procedure.

     (b) In the event that Executive's claim for benefits is denied in whole or
in part, he may appeal for a review of the decision by the Company. Such appeal
must be made within sixty (60) days after Executive has received actual or
constructive notice of the denial as provided above. An appeal must be submitted
in writing within such period and must:

          i. request a review by the Company of the claim for payment of the
     Deferred Compensation;

          ii. set forth all of the grounds upon which Executive's request for
     review is based and any facts in support thereof; and

          iii. set forth any issues or comments which Executive deems pertinent
     to the appeal.

The Company shall act upon the appeal within sixty (60) days after receipt
thereof unless special circumstances require an extension of the time for
processing, in which case a decision shall be rendered by the Company as soon as
possible, but not later than 120 days after the appeal is received by the
Company.

The Company shall make a full and fair review of the appeal and any written
materials submitted by Executive in connection therewith. The Company may
require Executive to submit such additional facts, documents or other evidence
as

<PAGE>

                                                                              23

the Company in its discretion deems necessary or advisable in making its
review. Executive shall be given the opportunity to review pertinent documents
or materials upon submission of a written request to the Company, provided the
Company finds the requested documents or materials are pertinent to the appeal.
On the basis of its review, the Company shall make an independent determination
of Executive's right to payment of the Deferred Compensation. The decision of
the Company on any claim for benefits shall be final and conclusive upon all
parties thereto.

In the event the Company denies the appeal in whole or in part, it shall give
written notice of the decision to Executive, which notice shall set forth, in a
manner calculated to be understood by Executive, the specific reasons for such
denial and which shall make specific reference to the pertinent provisions of
this Agreement (or other document) on which the Company's decision is based.

          (c) This Appendix B shall apply to a claim for payment of the Deferred
     Compensation only if the Company determines, upon the advice of counsel,
     that such application is necessary in order for the Deferred Compensation
     to comply with ERISA.

<PAGE>

                                                                              24

                                    EXHIBIT A

                          CONFIDENTIAL INFORMATION AND
                         INTELLECTUAL PROPERTY AGREEMENT

     AGREEMENT made as of ______________ 2000, by and between NEXMED (U.S.A.),
INC., a Delaware corporation (the "Company") and ___________________ (the
"Employee").

     WHEREAS:

     (1) The Employee is employed or about to be employed by the Company and the
Company requires that all of its employees, as a condition of employment by the
Company, enter into this Confidential Information and Intellectual Property
Agreement (the "Agreement") or similar agreement, and would not be willing to
employ the Employee unless Employee enters into this Agreement; and

     (2) The Employee is willing to enter into this Agreement and to strictly
adhere to its terms.

     NOW, THEREFORE, in consideration of the employment or the continuation of
the employment of the Employee by the Company, the parties hereto agree as
follows:

     1. Representations. Warranties and Acknowledgment of Employee.

     (a) The Employee hereby represents to the Company that, except to the
extent contemplated hereby or that the Employee has disclosed to the Company in
writing, the Employee is not bound by any agreement or any other previous or
existing business relationship which conflicts with or prevents the full
performance of the Employee's duties and obligations to the Company (including
the Employee's duties and obligations under this or any other agreement with the
Company) during the Employee's employment. (b) The Employee understands that the
Company does not desire to acquire from the Employee any trade secrets, know-how
or confidential business information the Employee may have acquired from others.
Therefore, the Employee agrees during his employment with the Company, the
Employee will not improperly use or disclose any proprietary information or
trade secrets of any former or concurrent employer, or any other person or
entity with whom the Employee has an agreement or to whom the Employee owes a
duty to keep such information in confidence.

          2. Confidential Information.

     (a) For purposes of this Agreement, "Confidential Information" means all
information, heretofore or hereafter developed or used by the Company (whether
or not reduced to written, electronic, magnetic or other tangible form) acquired
in any way by the Employee during the course of the Employee's employment with
the Company

<PAGE>

                                                                              25

and which is proprietary to the Company or which relates to any third party for
which the Company is under an obligation to keep confidential, concerning the
scientific, medical and pharmaceutical research, product development, products,
operations, marketing and business plans, activities, employees, consultants,
licensors, licensees, customers, business affairs of the Company or the
Company's licensees, distributors, business partners or customers, including,
without limitation, (i) all information concerning trade secrets of the Company,
including computer programs, system documentation, special hardware, product
hardware, related software development, computer systems, source code, object
code, manuals, formulae, processes, methods, machines, compositions, ideas,
improvements or inventions of the Company; (ii) all sales and financial
information concerning the Company; (iii) all customer and supplier lists; (iv)
all drawings, sketches, models, samples, data, technology, methodologies,
techniques, distribution plans, contractual arrangements, profits, sales,
pricing policies, operational methods, technical processes, other business
affairs and methods, plans for future developments and other technical and
business information relating to the business of the Company or the Company's
licensees, distributors, business partners or customers and all trademarks,
domain names, copyrights and patents and applications thereof, all inventions,
processes, studies, reports, research records, market surveys and know-how and
technical papers; and (v) all information in any way concerning the business or
affairs of the Company or the Company's licensees, distributors, business
partners or customers which was furnished to Employee by the Company or by the
Company's licensees, distributors, business partners or customers or otherwise
discovered by Employee during Employee's employment with the Company.

     (b) The Employee acknowledges that it is the policy of the Company to
maintain as secret and confidential all Confidential Information. The parties
hereto recognize that, by reason of Employee's employment by the Company, the
Employee has acquired or will acquire access to Confidential Information. The
Employee recognizes that all such Confidential Information is and shall remain
the sole property of the Company as its sole owner, free of any rights of the
Employee and acknowledges that the Company has a vested interest in assuring
that all such Confidential Information remains secret and confidential.
Therefore, the Employee agrees to exercise all reasonable precautions to protect
the integrity and confidentiality of Confidential Information in Employee's
possession and the Employee agrees that at all times from and after the date
hereof, Employee will not, directly or indirectly, without the prior written
consent of the Company, disclose to any person, firm, company or other entity
any Confidential Information, except to the extent that (i) any such
Confidential Information becomes generally available to the public or trade,
other than as a result of a breach by the Employee of this Section 2(b), or (ii)
any such Confidential Information becomes available to the Employee on a
non-confidential basis from a source other than the Company or any of its
employees or advisors; provided, that such source is not known by the Employee
to be bound by a confidentiality agreement with, or other obligation of secrecy
to, the Company or another party. In addition, it shall not be a breach of the
confidentiality obligations hereof if the Employee is required by law or legal
process to disclose any Confidential Information; provided, that in such case,
the Employee shall (i) give the Company the earliest notice possible that such
disclosure is or may be required, and (ii) cooperate with the Company, at the
Company's expense, in protecting, to the

<PAGE>

                                                                              26

maximum extent legally permitted, the confidential or proprietary nature of the
Confidential Information which must be so disclosed. The obligations of the
Employee under this Section 2(b) shall survive any termination of the Employee's
employment by the Company.

     (c) Upon termination of the Employee's employment with the Company,
Employee covenants and agrees to promptly return to the Company all items
constituting or containing Confidential Information (including all copies)
including, without limitation, all reports, data, documents, studies, notes,
specifications, or information, and will not retain any copies of such items.
Employee further covenants and agrees to immediately return to the Company all
equipment, devices or other property, which belong to the Company.

     3. Non-Solicitation of Employees.

Employee recognizes and acknowledges that it is essential for the proper
protection of the business of the Company that Employee be restricted during the
term of Employee's employment and for a one-year period following the
termination of Employee's employment with the Company from soliciting or
inducing any employee of the Company to leave the employ of the Company or to
encourage any other business entity to solicit or seek to hire any employee of
the Company. Therefore, during the term of the Employee's employment with the
Company and for a period of one (1) year following the termination of such
employment, Employee agrees that Employee shall not, directly or indirectly,
hire or seek to hire any employee of the Company or assist or influence any
business entity to hire or solicit for employment or take any other action which
would encourage any such employee to terminate such employee's employment by the
Company. For purposes of this Section 3, "employee" shall include any former
employee of the Company whose employment with the Company terminated less than
one (1) year prior to the termination of the employment with the Company of the
Employee.

     4. Non-Compete.

     In order to insure the protection of the Company's interest in maintaining
the confidentiality of its Confidential Information and to otherwise provide for
the proper protection of the business of the Company, the parties hereto agree
as follows:

     (a) Employee acknowledges that the nature of the Company's business renders
it highly likely that disclosure of the Employer's Confidential Information,
whether intentional or inadvertent, will occur if Employee becomes employed by a
competitor of the Company. Employee further acknowledges and agrees that
Employee's responsibilities with respect to the Company's business operations
and Employee's access to the Confidential Information would render the Employee
a potentially formidable competitor throughout the world because the Employer's
technology and trade secrets have worldwide application.

     (b) By reason of the foregoing, Employee agrees that during the term of
Employee's employment by the Company and for a period of one (1) year following
the termination of Employee's employment with the Company, Employee will not,
anyplace in the world, own, become employed by or participate in (whether as an
employee, consultant, officer, director, agent, or in any other capacity which
calls for the

<PAGE>

                                                                              27

rendering of personal services, advice, acts of management, operation or
control) any corporation, business, firm, or partnership, which competes,
directly or indirectly, with the Company (including, without limitation, which
competes with respect to any products or services sold or marketed by the
Company) at the time of the termination of the Employee's employment with the
Company. The foregoing shall not prohibit the Employee from owning in the
aggregate less than 2% of the common stock of any such competing company that is
subject to the reporting obligation of the Securities and Exchange Act of 1934,
as amended. While the parties acknowledge that the restrictions set forth in
this Section 4 are reasonable, in the event that a Court determines that any of
the covenants or provisions of this Agreement are unenforceable by reason of
duration, extent, geographical scope or otherwise, the parties contemplate and
agree that the Court making such determination shall reduce or modify the
applicable provision and shall enforce such reduced or modified provision to the
maximum extent deemed reasonable by the Court.

     5. Intellectual Property.

     (a) The Employee shall disclose and hereby assigns to the Company or its
nominee any and all of his right, title and interest in any inventions,
know-how, discoveries, improvements, original works of authorship, designs,
software, source code, object code, programs, formulas, processes, developments,
trade secrets, trademarks, copyrights, service marks, logos and related
proprietary information and materials, whether patentable, copyrightable,
subject to trademark registration, or not (collectively referred to as the
"Innovations"), which, during the term of the Employee's employment by the
Company (the "Employment Period"), the Employee may make or conceive either
solely or jointly with others and which:

          (i)   were made using equipment, supplies, facilities or trade secret
                information of the Company, or

          (ii)  were developed at least in part on the Company's time, or

          (iii) relate at the time of conception or reduction to practice either
                to the business of the Company or to the Company's or any of its
                affiliate's actual or demonstrably anticipated research or
                development, or

          (iv)  results from any work the Employee performs or performed for
                the Company.

     All such Innovations and the benefits thereof shall be owned exclusively in
perpetuity by the Company, free of any claims of the Employee.

     (b) In order to allow the Company to claim rights in those Innovations
which it owns or owns an interest in, the Employee shall promptly and fully
disclose in writing to the Company the subject matter of every Innovation made
or conceived by the Employee, either solely or jointly with others, and all
copyright, trademark, domain name and patent applications naming the Employee as
an author, co-author, owner, co-owner, inventor or a co-inventor during the
Employment Period whether or not the same are required by this Agreement to be
assigned to the Company. Upon the request of the Company, the Employee shall
make all reasonable efforts to provide further disclosure of

<PAGE>

                                                                              28

the aforesaid Innovations in which the Company may reasonably claim ownership or
for which the Company requires additional information in order to determine its
ownership rights. The Company shall maintain in confidence all disclosures made
hereunder of Innovations owned by the Employee.

     (c) An Innovation shall be deemed to have been made during the Employment
Period if during such period the Innovation was conceived, first actually
reduced to practice or otherwise put in a tangible form, and any patent
application, trademark application, domain name application or copyright
application reasonably relating to the business of the Company filed within six
months after termination of the Employment Period shall be presumed to relate to
an Innovation which was made during the Employment Period unless the Employee
can provide satisfactory evidence to the contrary.

     (d) With respect to any Innovations in which the Company owns an interest
pursuant to this Section 5, the Employee agrees, during and after the Employment
Period and upon the Company's reasonable request, to execute, acknowledge, and
deliver all such further documents (which shall be prepared and paid for by the
Company) including applications for letters patent, trademark, domain name
and/or copyright registration, as may be necessary or, in the opinion of the
Company, advisable, to obtain letters patent and/or trademark, domain name or
copyright registration for Innovations in the United States and in any other
country, and the right to claim priority based on the first filed patent
application anywhere in the world, and to vest title thereto in the Company and
its successors, assigns or nominees. The Company shall have the sole and
exclusive right to seek copyright and/or patent and/or trademark, domain name or
trade name protection in its own name, as applicable, for any of the foregoing
Innovations, and to seek any extensions or renewals thereof.

     (e) Upon the termination of Employee's employment with the Company, the
Employee shall not (a) take any of the Company's property including, but not
limited to, new product information, blueprints, drawings, sketches, notebooks,
computer programs, formulas, data, listings, specifications and documents, or
copies thereof, and any items relating to or exhibiting the Company's trade
secrets or Confidential Information or (b) use for any purpose the residuals
resulting from access to or work with those items set forth in clause (a)
hereof. The term "residuals" means information in non-tangible form, including
ideas, concepts, know-how or techniques which may be retained in the mind of the
Employee, even if the Employee made no effort to refresh the Employee's
recollection in anticipation of or in conjunction with the use of said
residuals. Further, the Employee shall not intentionally memorize the
information so as to reduce it to a non-tangible form for the purpose of
creating a residual.

     (f) The Employee agrees that any copyrightable works made by the Employee
(solely or jointly with others) during the Employment Period that are otherwise
covered by the terms hereof and that are prosecutable by copyright, shall be
deemed to be "works made for hire," as that term is defined in the United States
Copyright Act (17 U.S.C. section 101). Accordingly, the Company shall be the
sole and exclusive author and owner of all such copyrightable works and all
right, title and interest therein and thereto, including, without limitation,
all copyrights (and all renewals and extensions thereof). To the extent that any
of such works are not determined to be a work for hire,

<PAGE>

                                                                              29

the Employee hereby irrevocably, permanently, exclusively and absolutely assigns
and grants to the Company all title, right and interest in and to such works,
including, without limitation, all copyrights therein (and all renewals and
extensions thereof). The Company shall have the sole and exclusive right to use
and exploit such works, in whole or in part, in any media or technology known or
hereafter devised, in perpetuity. The Company's rights in and to such works may
be assigned and licensed without limitation, and any such assignment or license
shall be binding on the Employee and shall inure to the benefit of such assignee
or licensee. The Employee shall have no rights of consultation and/or approval
with respect to the Company's exploitation, revision and/or use of such works.
Moreover, the Employee hereby waives, forfeits, relinquishes and abandons all
"moral rights" (as said term is commonly understood) and all rights of
attribution and integrity that the Employee may otherwise have had with respect
to such works through the universe, and all rights the Employee might otherwise
have had under the Visual Artists Rights Act of 1990.

     (g) As to any Innovations in which the Employee owns an interest and the
Company does not, whether or not invented, created or acquired prior to the date
hereof, the Employee will not without the express written consent of the
Company, incorporate or use, or participate in the incorporation or use, of any
such Innovations into any products or services of the Company, and upon
discovery that any such Innovations have been, or are being, or are about to be,
incorporated or used in the Company's products or services or a product or
service being designed or planned for or by the Company in violation of any
rights the Employee may claim, the Employee shall give the Company written
notice of that fact, together with such detail as is then known, within three
(3) days of such discovery. The Employee agrees that if, in breach of these
provisions, the Employee incorporates or uses, or participates in the
incorporation or use, of any such Innovations in any products or services of the
Company, or upon discovery that such Innovations have been, are being or are
about to be incorporated or used in a product or service of the Company, or a
product or service being designed or planned for or by the Company, and/or the
Employee does not give the Company written notice of that fact, together with
such detail as is then known, within three (3) days of such discovery, then to
that extent, the Company shall have a royalty-free, transferable, nonexclusive
license to make, have made, reproduce, use and sell and otherwise practice any
such Innovations.

     6. Power of Attorney.

     The Employee, by execution of this Agreement, irrevocably constitutes and
appoints the Company with full power of substitution, to be the Employee's true
and lawful attorney to execute, acknowledge, swear and file all instruments and
documents, and to take any action which shall be deemed to be necessary,
appropriate or desirable to effectuate this Agreement. The power of attorney
granted herein shall be deemed to be coupled with an interest and shall be
irrevocable and survive the occurrence of the death, disability or bankruptcy of
the Employee.

     7. Remedies For Employee Violations.

     Employee acknowledges and agrees that the Company would be irreparably
harmed if the Employee violated any of the covenants and agreements set forth in
this Agreement or if any of such covenants and agreements were not specifically
enforced.

<PAGE>

                                                                              30

Employee further agrees that the breach or threatened breach of any of the
covenants or agreements set forth in Sections 2, 3, 4, or 5 of this Agreement
will result in continuing and irreparable harm to the Company for which the
Company would not have an adequate remedy at law. Therefore, the Employee
acknowledges and agrees that, in addition to any other remedy which the Company
may have at law or in equity, the Company shall be entitled to injunctive relief
or other equitable remedies in the event of any such breach or threatened
breach. The Employee further acknowledges and agrees that monetary damages would
be insufficient to compensate the Company in the event of a breach or threatened
beach by the Employee of any of such covenants and agreements, and that the
Company shall be entitled to specific performance of the Employee's obligations
pursuant to such covenants or agreements.

     8. Company's Affiliates

     The parties hereto acknowledge and agree that, for purposes of Sections 2,
3, 4, 5, and 7 of this Agreement, the "Company" shall also refer to the
Company's affiliated corporations, including, without limitation, NexMed
(Holdings), Inc.

     9. Company's Telecommunications Systems

     Employee acknowledges and agrees that the Employee is being provided access
to the Company's telecommunications, networking or information processing
systems (including without limitation, stored computer files, e-mail messages,
and voice messages) for the Company's business purposes and that Employee has no
expectation of privacy with respect to Employee's use of any of such systems.
The Company may, without notice and in its sole discretion, monitor or review
Employee's use of such systems (and any other Company-supplied systems or
equipment) and any files or messages created by or received by Employee through
use of such systems.

     10. Employment At Will. The parties hereto acknowledge that this Agreement
is not an employment agreement and that Employee is employed on an "at will"
basis and that either Employee or the Company may terminate Employee's
employment at any time, with or without cause.

     11. Miscellaneous. This Agreement: (a) is binding upon and shall inure to
the benefit of the parties hereto, their respective affiliates, heirs,
executors, assigns, administrators, and successors; (b) shall be governed by,
and construed in accordance with, the internal laws of the State of New Jersey,
without regard to the conflicts of laws provisions thereof; (c) may not be
amended or modified, except by a written instrument signed by the parties
hereto; and (d) supersedes and voids any and all prior understandings and
agreements, whether written or oral, between the Company and the Employee
relating to the subject matter of this Agreement, which contains the entire
understanding of the parties relating to such subject matter.

     12. Jurisdiction. Each of the parties hereto consents and agrees to the
jurisdiction of the New Jersey Superior Court, Mercer County, for the
adjudication of any disputes as to the parties' respective rights and
obligations under this Agreement.

<PAGE>

                                                                              31

     13. Severability. The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of the other
provisions of this Agreement, which shall remain in full force and effect.

     IN WITNESS WHEREORF, the parties hereto have executed this Agreement as of
the date first above written.

DATED: ______________________           ________________________________________

DATED: ______________________           NEXMED (U.S.A.), INC.

                                        BY:____________________________________

                                                 VIVIAN LIU, VICE PRESIDENT<PAGE>

                                                 Commercial Equipment Financing

WILLIAM B. STICKLE
401 MERRITT7
SECOND FLOOR
NORWALK, CT 06856
203-229-1901 / FAX: 203-229-1985
INTERNET:         WILLIAM.STICKLE~GECAPITAL.COM

February 6, 2001

Mr. Joseph Mo, Ph.D.
President & Chief Executive Officer
NexMed, Inc.
350 Corporate Boulevard
Robbinsville, NJ 08691

Dear Dr. Mo:

General Electric Capital Corporation ("GECC") is pleased to submit the following
lease proposal for your consideration:

LESSEE:

NexMed, Inc.

LESSOR:

GE Capital or one of its wholly-owned subsidiaries

EQUIPMENT:

Group 1: New ERP System and all related costs for the internal use of the
Lessee.

Group 2: New laboratory, manufacturing and packaging Equipment and new furniture
and computer hardware for the internal use of the Lessee.

The anticipated mix of Equipment is summarized in Attachment A.

All final Equipment must be acceptable to Lessor.

<PAGE>
EQUIPMENT LOCATION:

All within the continental United States. Anticipated sites are (i) Lessee's
headquarters at the above address and (ii) at Lessee's new manufacturing
facility in East Windsor, NJ.

EQUIPMENT COST:

$5,000,000.00 lease line of credit of which $2,500,000.00 is for Equipment Group
1 and $2,500,000.00 is for Equipment Group 2 (See Attachment A).

DELIVERY ASSUMPTIONS:
-------- -----------

January 1, 2001 through March 31, 2002.

LEASE TERM:

Each Schedule shall have a fixed term of 42 months.

BASIC TERM COMMENCEMENT DATES:
           ------------ ------

Lessee shall make its first rental payment(s) in advance. Such advance rental
payment(s) shall be due upon execution of documents.

RENTAL PAYMENT RATE:
------ ------- ----

Group 1: 2.828% of the Equipment Cost per month for 42 months.

Group 2: 2.840% of the Equipment Cost per month for 42 months.

LEASE EXPIRATION PURCHASE OPTION:
                 -------- -------

$1.00

ADDITIONAL COLLATERAL:

Lessee shall provide to Lessor a continuing Letter of Credit covering all
original Equipment costs related to Equipment chosen for Equipment Group 1 --
the ERP System and all consulting, training, installation, software and other
such applicable soft costs. Based on information provided by the Lessee, these
costs will approximate $2,500,000.00.

FINANCIAL COVENANTS:
--------- ---------

To be mutually agreed upon by Lessee and Lessor.

<PAGE>

This proposal is based upon the following additional terms and conditions:

PURCHASE OF EQUIPMENT:
-------- -- ---------
Lessee would submit its order for the equipment to the vendor. Lessor would take
an assignment of Lessee s purchase order. Such assignment would be conditioned
upon the leasing of the Equipment by Lessee from Lessor. Lessee understands that
any Equipment delivered after the Last Delivery Date would not be covered by
this proposal.

NET LEASE:
--- -----
The proposed lease would be a net lease. Without limiting the generality of the
foregoing, Lessee would be responsible for all expenses, maintenance, insurance
and taxes relating to the purchase, lease, possession and use of the Equipment.

INSURANCE:
Lessee would bear all risk of loss or damage to the Equipment. Lessee would be
responsible to keep the Equipment insured with companies acceptable to Lessor
and for such amounts required by Lessor, including, but not limited to,
insurance for damage to or loss of the Equipment and liability coverage. All
such insurance policies must be satisfactory to Lessor.

WARRANTIES:
Lessor would lease the Equipment to Lessee on an AS IS BASIS. However, Lessor
would assign to Lessee all warranties, guarantees and services provided by the
manufacturer or vendor (to the extent that they are assignable).

DOCUMENTATION AND TRANSACTIONAL COSTS:

Standard GECC Master Lease and Lease Schedule for this type of equipment would
be utilized. Any changes to the document must be approved by GECC legal counsel.
A fee of $2,500.00 shall be charged for the Master Lease documentation and the
first lease schedule. Subsequent lease schedules will carry a fee of $250.00 per
lease schedule for documentation, overnight mail and search and filing charges.
Lessee will be responsible for all costs it incurs with respect to the
transaction.

RATE INDEX:

The above Rental Factor assumes an average three (3) -year Treasury Note yield
of 4.95%. The Rental Factor will be adjusted accordingly for any difference in
the average three-(3) year Treasury Note yield, as applicable.

PROPOSAL FEE:
-------- ---

A Proposal Fee of $25,000.00 shall be due upon acceptance of this proposal to
begin the investment approval process. This fee shall be applied to the first
scheduled rental payment or returned to the Lessee in the event that GECC does
not approve the transaction. If this transaction is not fully closed, then GECC
shall retain the Proposal Fee as liquidated damages.

This letter is an expression by GECC of its interest in considering a lease
transaction on the

<PAGE>

general terms and conditions outlined above. Except for the provisions
concerning the Proposal Fee (set forth above), this letter is not intended to
and does not create any binding legal obligation on the part of either party.
THIS LETTER IS NOT, AND IS NOT TO BE CONSTRUED AS, A COMMITMENT BY GECC OR ANY
OF ITS SUBSIDIARIES TO ENTER INTO THE PROPOSED LEASE TRANSACTION. Neither GECC
nor its subsidiary will be obligated to provide any financing until the
satisfactory completion of its investment review and analysis and a field audit,
the receipt of all requisite approvals by GECC management, and the prior
execution and delivery of final legal documentation acceptable to all parties
and their counsel. Please acknowledge your consent to the terms outlined above
by signing a copy of this letter and returning it with you check for the
Proposal Fee before February 9, 2001.

Sincerely,

/s/ William B. Stickle

William B Stickle

ACCEPTED: NexMed , Inc.

By: /s/ Joseph Mo, Ph.D.
Title: President & Chief Executive Officer
Date: February 8, 2001

                                  ATTACHMENT A

ESTIMATED CATEGORIES OF EQUIPMENT

CATEGORV                                    AMOUNT                   PERCENTAGE
-------------------------------------------------------------------------------
GROUP 1:
ERP System, Software, and all other $2,500,000                         50.0%
"Soft" Collateral

<PAGE>

GROUP 2:

Lab Equipment                               $1,250,000                 25.0%

Manufacturing, Packaging & Furniture        $1,000,000                 20.0%

Computer Hardware                            $ 250.000                  5.0%

TOTAL                                       $5,000,000                100.0%

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00036-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00036-of-00352.parquet"}]]